Matthew Chersich

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

François Venter, Michelle Moorhouse, Simiso Sokhela et al. · New England Journal of Medicine · 2019 · 684 citations · Full text

Inequities in access to health care in South Africa

Bronwyn Harris, Jane Goudge, John E. Ataguba et al. · Journal of Public Health Policy · 2011 · 494 citations

Healthcare Access, Healthcare Provision, Health Policy +6

‘We are despised in the hospitals’: sex workers' experiences of accessing health care in four African countries

Fiona Scorgie, Daisy Nakato, Eric Harper et al. · Culture Health & Sexuality · 2013 · 265 citations

Social Sciences, Gender Studies, Medical Anthropology +16

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

François Venter, Simiso Sokhela, Bryony Simmons et al. · The Lancet HIV · 2020 · 249 citations

Week 96, Treatment And Prevention, Antiviral Drug Development +9

Characteristics and Outcomes of Adult Patients Lost to Follow-Up at an Antiretroviral Treatment Clinic in Johannesburg, South Africa

Rishikesh Dalal, Catherine MacPhail, Mmabatho Mqhayi et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 194 citations